SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 1 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $5,000 | -99.9% | 28 | -100.0% | 0.00% | -100.0% |
| Q4 2014 | $9,173,000 | -51.1% | 79,806 | -33.5% | 0.01% | -57.1% |
| Q3 2014 | $18,764,000 | +11.1% | 120,098 | -12.3% | 0.02% | +5.0% |
| Q2 2014 | $16,885,000 | +97.6% | 136,893 | +66.0% | 0.02% | +81.8% |
| Q1 2014 | $8,545,000 | -37.8% | 82,477 | -46.0% | 0.01% | -38.9% |
| Q4 2013 | $13,728,000 | +13.5% | 152,631 | -15.6% | 0.02% | 0.0% |
| Q3 2013 | $12,093,000 | -28.9% | 180,817 | -29.7% | 0.02% | -30.8% |
| Q2 2013 | $17,014,000 | – | 257,204 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $34,482,000 | 18.91% |
| NORTH RUN CAPITAL, LP | 490,000 | $56,321,000 | 5.02% |
| Visium Asset Management, LP | 3,076,092 | $353,568,000 | 4.99% |
| BOW STREET LLC | 112,979 | $12,986,000 | 4.60% |
| 1492 Capital Management LLC | 62,397 | $7,172,000 | 4.49% |
| CLOVIS CAPITAL MANAGEMENT LP | 115,000 | $13,218,000 | 3.70% |
| Paulson & Co. | 5,806,000 | $667,342,000 | 3.45% |
| HealthCor Management, L.P. | 525,000 | $60,344,000 | 3.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 158,500 | $18,218,000 | 3.10% |
| AMI ASSET MANAGEMENT CORP | 299,276 | $34,399,000 | 3.01% |